Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,489 public trials 1,474 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Active, Not Recruiting

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT05242484

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Valley Gastroenterology Medical Group Arcadia, California, United States
  • Southern California Research Center Coronado, California, United States
  • Om Research LLC Lancaster, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 403 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

NCT02997228

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 445 locations
View Trial Details
Active, Not Recruiting

A Long-term Extension Study of Ustekinumab in Pediatric Participants

NCT05092269

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +19 more
Locations
  • Children's Center For Digestive Healthcare, Llc Atlanta, Georgia, United States
  • Mount Sinai New York, United States
  • Levine Childrens at Atrium Health Charlotte, North Carolina, United States
  • Pediatric Specialists Of Virginia Fairfax, Virginia, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

NCT02888743

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1411 locations
View Trial Details
Active, Not Recruiting

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

NCT05217446

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic Building - Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Mount Sinai Cancer Center Miami Beach, Florida, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

Adaptive Symptom Self-Management Immunotherapy Study

NCT05715255

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • Valleywise Health Medical Center Phoenix, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details

Related conditions